Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$474,808
New position
Shares Held
2,504
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#864
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAX Financial Group, LLC holds $3,929,562 across 7 Drug Manufacturers - General names. AZN ranks #5 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,103 | $1,322,971 | |
| 2 | NVO |
Novo Nordisk A S
|
13,437 | $644,169 | |
| 3 | JNJ |
Johnson & Johnson
|
2,114 | $536,892 | |
| 4 | ABBV |
AbbVie Inc.
|
2,019 | $508,061 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
2,504 | $474,808 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,794 | $226,653 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,808 | 2,504 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||